Chemotherapy-induced nausea and vomiting in Portugal: incidence versus healthcare provider estimations and effect on quality of life

By Dinis Joséé   Wisniewski Tami   Moreira Antóónio   Raposo Joãão   Ma Larry   Burke Thomas A  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 595-602

Future Medicine

Access to resources Recommend Favorite

Does previous chemotherapy‐induced nausea and vomiting predict postoperative nausea and vomiting?

By  

ACTA ANAESTHESIOLOGICA SCANDINAVICA, Vol. 59, Iss. 9, 2015-10 ,pp. : 1145-1153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting

By Meiri Eyal   Jhangiani Haresh   Vredenburgh James J.   Barbato Luigi M.   Carter Frederick J.   Yang Hwa-Ming   Baranowski Vickie  

Current Medical Research and Opinion, Vol. 23, Iss. 3, 2007-03 ,pp. : 533-543

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy-Induced Nausea and Vomiting in the Treatment of Gastrointestinal Tumors and Secondary Prophylaxis with Aprepitant

By  

Oncology Research and Treatment, Vol. 32, Iss. 1-2, 2009-01 ,pp. : 30-34

Karger

Access to resources Recommend Favorite

Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT₃ receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States

By Schwartzberg Lee   Morrow Gary   Balu Sanjeev   Craver Chris   Gayle Julie   Cox David  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1613-1622

Informa Healthcare

Access to resources Recommend Favorite